-
EP4110371
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4110371
| EP4110371 - METHODS OF STIMULATING BONE GROWTH WITH ABALOPARTIDE AND DENOSUMAB [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 02.12.2022 Database last updated on 12.07.2024 | |
| Former | The international publication has been made Status updated on 30.07.2021 | ||
| Former | unknown Status updated on 08.02.2021 | Most recent event Tooltip | 29.01.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Radius Health, Inc. 22 Boston Wharf Road, 7th Floor Boston MA 02210 / US | [2023/01] | Inventor(s) | 01 /
HATTERSLEY, Gary 14 Woodman Drive Stow, Massachusetts 01775 / US | 02 /
YATES, John 2590 Sumac Avenue Boulder, Colorado 80304 / US | 03 /
MITLAK, Bruce 950 Winter St. Waltham, Massachusetts 02451 / US | [2023/01] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2023/01] | Application number, filing date | 21702314.2 | 22.01.2021 | [2023/01] | WO2021IB50513 | Priority number, date | US202062965214P | 24.01.2020 Original published format: US 202062965214 P | [2023/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021149012 | Date: | 29.07.2021 | Language: | EN | [2021/30] | Type: | A1 Application with search report | No.: | EP4110371 | Date: | 04.01.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.07.2021 takes the place of the publication of the European patent application. | [2023/01] | Search report(s) | International search report - published on: | EP | 29.07.2021 | Classification | IPC: | A61K38/29, A61P19/10, A61K39/395 | [2023/01] | CPC: |
A61K38/29 (EP,US);
A61K39/39541 (EP);
A61K39/3955 (US);
A61P19/10 (EP,US);
C07K16/2875 (EP);
A61K2039/505 (US)
| C-Set: |
A61K38/29, A61K2300/00 (EP);
A61K39/39541, A61K2300/00 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/01] | Title | German: | VERFAHREN ZUR STIMULIERUNG DES KNOCHENWACHSTUMS MIT ABALOPARTID UND DENOSUMAB | [2023/01] | English: | METHODS OF STIMULATING BONE GROWTH WITH ABALOPARTIDE AND DENOSUMAB | [2023/01] | French: | MÉTHODES DE STIMULATION DE LA CROISSANCE OSSEUSE FAISANT INTERVENIR L'ABALOPARATIDE ET LE DENOSUMAB | [2023/01] | Entry into regional phase | 24.11.2022 | National basic fee paid | 24.11.2022 | Designation fee(s) paid | 24.11.2022 | Examination fee paid | Examination procedure | deleted | Deletion: Application deemed to be withdrawn, date of legal effect [2023/01] | 24.11.2022 | Examination requested [2023/01] | 24.11.2022 | Date on which the examining division has become responsible | 07.07.2023 | Despatch of communication of loss of particular rights: Claims {1} | 15.09.2023 | Amendment by applicant (claims and/or description) | Request for further processing for: | 15.09.2023 | Request for further processing filed | 15.09.2023 | Full payment received (date of receipt of payment) Request granted | 21.09.2023 | Decision despatched | The application is deemed to be withdrawn due to non-payment of designation fees PT, MC, FI, ES, EE, DK, DE, CZ, CY, CH, BG, BE, AT, AL, TR, SM, SK, SI, SE, RS, RO, PL, NO, NL, MT, MK, LV, LU, LT, IT, IS, IE, HU, HR, GR, GB, FR | 24.11.2022 | Request for further processing filed | 24.11.2022 | Full payment received (date of receipt of payment) Request granted | 05.12.2022 | Decision despatched | 24.11.2022 | Request for further processing filed | 24.11.2022 | Full payment received (date of receipt of payment) Request granted | 05.12.2022 | Decision despatched | The application is deemed to be withdrawn due to non-payment of the filing fee | 24.11.2022 | Request for further processing filed | 24.11.2022 | Full payment received (date of receipt of payment) Request granted | 05.12.2022 | Decision despatched | The application is deemed to be withdrawn due to non-payment of the examination fee | 24.11.2022 | Request for further processing filed | 24.11.2022 | Full payment received (date of receipt of payment) Request granted | 05.12.2022 | Decision despatched | 24.11.2022 | Request for further processing filed | 24.11.2022 | Full payment received (date of receipt of payment) Request granted | 05.12.2022 | Decision despatched | Fees paid | Renewal fee | 24.11.2022 | Renewal fee patent year 03 | 29.01.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]WO2010022176 (FERRING INT CT SA [CH], et al) [X] 1,2,13,14,18-20 * paragraph [0059] *[Y] 1-21; | [XY]WO2019035919 (UNIV MARYLAND [US], et al) [X] 1,2,13,14,18-20 * page 63, paragraph 4 * [Y] 1-21; | [XY] - LEDER BENJAMIN Z, "Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy", CURRENT OSTEOPOROSIS REPORTS, CURRENT SCIENCE INC., US, vol. 15, no. 2, doi:10.1007/S11914-017-0353-4, ISSN 1544-1873, (20170316), pages 110 - 119, (20170316), XP036237633 [X] 1-5,13,14,18-20 * page 110, column 1, paragraph 1 - paragraph 3 * * page 113, column 2, paragraph 2 - paragraph 3 * * page 115, column 2, paragraph 2 * * page 116, column 1, paragraph 2; table 1 * [Y] 1-21 DOI: http://dx.doi.org/10.1007/s11914-017-0353-4 | [XY] - HARSLØF TORBEN ET AL, "New horizons in osteoporosis therapies", CURRENT OPINION IN PHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS, NL, (20160315), vol. 28, doi:10.1016/J.COPH.2016.02.012, ISSN 1471-4892, pages 38 - 42, XP029529891 [X] 1-5,13,14,18-20 * page 40, column 2, paragraphs 3,4 * [Y] 1-21 DOI: http://dx.doi.org/10.1016/j.coph.2016.02.012 | [XY] - VIDAL MARITZA ET AL, "Osteoporosis: a clinical and pharmacological update", CLINICAL RHEUMATOLOGY, ACTA MEDICA BELGICA, BRUXELLES, BE, vol. 38, no. 2, doi:10.1007/S10067-018-4370-1, ISSN 0770-3198, (20181212), pages 385 - 395, (20181212), XP036693654 [X] 1,2,4,13,14,18-20 * page 387, column 2, paragraph 2 - paragraph 3 * [Y] 1-21 DOI: http://dx.doi.org/10.1007/s10067-018-4370-1 | by applicant | US5969095 | US6740522 | US7097834 | US7364736 | WO2008063279 | US7411050 | US7803770 | WO2012145665 | WO2013082427 | WO2017062727 | WO2017062922 | WO2017184355 | WO2019077519 | US10568937 | US10695289 | WO2020174443 | - CUMMINGS, JBMR, (20170200), vol. 33, no. 2, pages 190 - 198 | - LEDER, Lancet, (20150919), vol. 386, no. 9999 | - ROSEN CJ., N Engl J Med, (20050000), vol. 353, pages 595 - 603 | - SILVIA et al., Curr. Opin Pharmacol, (20150000), vol. 22, pages 41 - 50 | - MIAO et al., Endocrinology, (20040000), vol. 145, pages 2046 - 2053 | - MIAO et al., J Clin Invest, (20050000), vol. 115, pages 2322 - 11 | - TELLA et al., Cureus, vol. 9, no. 5, page e1300 | - HOLFORD, N. H. G.SCHEMER, L. B., Clin. Pharmacokinet., (19810000), vol. 6, pages 429 - 453 | - LOEWE, S.MUISCHNEK, H., Arch. Exp. Pathol Pharmacol., (19260000), vol. 114, pages 313 - 326 | - CHOU, T. C.TALALAY, P., Adv. Enzyme Regul., (19840000), vol. 22, pages 27 - 55 | - "Recommendations for the Clinical Evaluation of Agents for Treatment of Osteoporosis: Consensus of an Expert Panel", Journal of Bone and Mineral Research, (20080000), vol. 23, pages 159 - 165 | - SMITH et al., Bone, (20130000), vol. 57, pages 116 - 122 |